English
简体中文
繁體中文
客服热线:400-1616-289
登录
注册
会议论文
Safety, tolerability, and preliminary antitumor activity of sitravatinib plus tislelizumab (TIS) in patients (pts) with unresectable locally advanced or metastatic gastric cancer/gastroesophageal junction cancer (GC/GEJC)
Chen, Zhendong; Bai, Yuxian; Zhang, Tao; Ying, Jieer; Lin, Xiaoyan; Yang, Liu; Wang, Jun; Zhang, Juan; Yu, Fan; Fei, Cong; Huang, Ruiqi; Li, Jin
华中科技大学; 哈尔滨医科大学
ASCO Gastrointestinal Cancers Symposium
2022-2-1
DOI: 10.1200/JCO.2022.40.4_suppl.281
1
被引
8
阅读
引用
收藏
分享
相关
加载中…
文献加载失败,请重试
重试